Evaluation of eltrombopag in patients with aplastic anemia in real-world experience

BACKGROUND: Although eltrombopag has recently been approved for treating AA, the effects of its clinical use remain unknown. METHODS: We retrospectively analyzed 11 patients with AA, who had been treated with eltrombopag from August 2017 to May 2018. RESULTS: Overall response rate was 55%. There was...

Descripción completa

Detalles Bibliográficos
Autores principales: Konishi, Akiko, Nakaya, Aya, Fujita, Shinya, Satake, Atsushi, Nakanishi, Takahisa, Azuma, Yoshiko, Tsubokura, Yukie, Saito, Ryo, Hotta, Masaaki, Yoshimura, Hideaki, Ishii, Kazuyoshi, Ito, Tomoki, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416522/
https://www.ncbi.nlm.nih.gov/pubmed/30911464
http://dx.doi.org/10.1016/j.lrr.2019.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416522/
https://www.ncbi.nlm.nih.gov/pubmed/30911464
http://dx.doi.org/10.1016/j.lrr.2019.03.002

Ejemplares similares